Lakewood-Amedex Biotherapeutics

(NASDAQ) LABT

Current Price$2.70

Market Cap$4.81M

Since IPO (2026)-97%

5 YearN/A

1 YearN/A

1 Month-56%

Lakewood-Amedex Biotherapeutics Financials at a Glance

Market Cap

$4.81M

Revenue (TTM)

$0.00

Net Income (TTM)

-$4.23

EPS (TTM)

-$8.80

P/E Ratio

-0.31

Dividend

$0.00

Beta (Volatility)

-0.84 (Low)

Dividend

$0.00

Beta (Volatility)

-0.84 (Low)

Price

$2.70

Volume

774,625.332

Open

$3.15

Price

$2.70

Volume

774,625.332

Open

$3.15

Previous Close

$2.75

Daily Range

$2.61 - $3.25

52-Week Range

$2.61 - $98.20

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

-0.84 (Low)

Price

$2.70

Volume

774,625.332

Open

$3.15

Previous Close

$2.75

Daily Range

$2.61 - $3.25

52-Week Range

$2.61 - $98.20

Estimated Earnings Date

N/A

LABT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lakewood-Amedex Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Kelvin Cooper, PhD

Website

www.lakewoodamedex.com

Headquarters

University Park, FL 34201, US

LABT Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-3.23%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$4.81M

Shares Outstanding

1.75M

Volume

774.63K

Avg. Volume

290.52K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$886.75K

EBITDA

-$886.19K

Operating Cash Flow

-$349.69K

Capital Expenditure

$0.00

Free Cash Flow

-$349.69K

Cash & ST Invst.

$11.71K

Total Debt

$1.76M

Lakewood-Amedex Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.81M

N/A

Market Cap/Employee

$962.94K

N/A

Employees

N/A

Net Income

-$923.29K

N/A

EBITDA

-$886.19K

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$11.71K

N/A

Total Debt

$1.76M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$10.30K

N/A

Short Term Debt

$1.75M

N/A

Return on Assets

N/A

Return on Invested Capital

N/A

Free Cash Flow

-$349.69K

N/A

Operating Cash Flow

-$349.69K

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,451.00-0.00%

^DJIDJI

^DJIDJI$52,612.49+0.01%

^IXICNASDAQ

^IXICNASDAQ$25,742.06-0.01%

BTCBitcoin

BTCBitcoin$61,755.00+0.03%

SPCXSPCX

SPCXSPCX$158.91+0.01%

AAPLAAPL

AAPLAAPL$307.20+0.04%

AMZNAMZN

AMZNAMZN$244.08+0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

Questions About LABT

What is the current price of Lakewood-Amedex Biotherapeutics?

Lakewood-Amedex Biotherapeutics is trading at $2.75 per share.

What is the 52-week range for Lakewood-Amedex Biotherapeutics?

Over the past 52 weeks, Lakewood-Amedex Biotherapeutics has traded between $2.61 and $98.20.

How much debt does Lakewood-Amedex Biotherapeutics have?

As of the most recent reporting period, Lakewood-Amedex Biotherapeutics reported total debt of $1.76M.

How much cash does Lakewood-Amedex Biotherapeutics have on hand?

Lakewood-Amedex Biotherapeutics reported $11.71K in cash and cash equivalents in its most recent financial results.

What is Lakewood-Amedex Biotherapeutics’s dividend yield?

Lakewood-Amedex Biotherapeutics does not currently have a dividend yield.

Lakewood-Amedex Biotherapeutics

Lakewood-Amedex Biotherapeutics Financials at a Glance

LABT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lakewood-Amedex Biotherapeutics

LABT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lakewood-Amedex Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LABT

What is the current price of Lakewood-Amedex Biotherapeutics?

What is the 52-week range for Lakewood-Amedex Biotherapeutics?

How much debt does Lakewood-Amedex Biotherapeutics have?

How much cash does Lakewood-Amedex Biotherapeutics have on hand?

What is Lakewood-Amedex Biotherapeutics’s dividend yield?

Premium Investing Services